Which histopathological feature best distinguishes AL amyloidosis from AA amyloidosis?

Explanation

## Distinguishing AL from AA Amyloidosis ### Key Structural and Immunological Differences **Key Point:** AL (light-chain) amyloidosis is composed of misfolded immunoglobulin light chains (κ or λ), while AA amyloidosis is composed of serum amyloid A, an acute-phase reactant. This fundamental difference drives their clinical and pathological distinctions. ### Comparative Features | Feature | AL Amyloidosis | AA Amyloidosis | |---------|---|---| | **Amyloid precursor** | Misfolded immunoglobulin light chains (κ or λ) | Serum amyloid A (acute-phase protein) | | **Primary organs involved** | Heart, peripheral nerves, soft tissues | Kidneys, liver, spleen, GI tract | | **Cardiac involvement** | Common (restrictive cardiomyopathy, arrhythmias) | Rare | | **Peripheral neuropathy** | Frequent (autonomic and sensorimotor) | Uncommon | | **Immunofluorescence** | Light chain restriction (κ or λ) | Negative for light chains | | **Associated conditions** | Plasma cell dyscrasias, multiple myeloma | Chronic infections (TB, osteomyelitis), chronic inflammation (RA, IBD) | | **Renal involvement pattern** | Glomerular (nodular deposits) | Glomerular (diffuse) | ### Why This Distinction Matters **High-Yield:** The presence of **light chain restriction on immunofluorescence microscopy** is the gold-standard discriminator. AL amyloidosis will show either κ or λ restriction, while AA amyloidosis shows no light chain staining. **Clinical Pearl:** AL amyloidosis patients often present with cardiac symptoms (dyspnea, syncope, heart failure) or neuropathic symptoms (paresthesias, orthostatic hypotension), whereas AA amyloidosis typically presents with nephrotic syndrome and progressive renal failure. **Mnemonic:** **AL = Amyloid Light-chain** (remember: **A**L has **A**ntigen from **L**ight chains; cardiac and nerve involvement). **AA = Amyloid **A**cute-phase** (remember: **A**A is from **A**cute-phase protein; kidney and liver involvement). ### Diagnostic Approach ```mermaid flowchart TD A[Amyloid suspected]:::outcome --> B{Tissue biopsy:<br/>Congo red + apple-green<br/>birefringence?}:::decision B -->|Yes| C[Confirm amyloidosis]:::action C --> D{Immunofluorescence:<br/>Light chain restriction?}:::decision D -->|κ or λ positive| E[AL Amyloidosis]:::outcome D -->|Negative| F[AA Amyloidosis]:::outcome E --> G[Cardiac/nerve involvement<br/>Plasma cell disorder workup]:::action F --> H[Renal/hepatic involvement<br/>Search for chronic infection/inflammation]:::action ``` **Key Point:** Congo red positivity and apple-green birefringence are present in BOTH types — these confirm amyloidosis but do NOT distinguish between them. Immunofluorescence is mandatory for subtyping.